LaMattina on Angell

John LaMattina takes on Marcia Angell and her recent interview. It sounds like he made it farther into the podcast than I could: “The drug companies do almost no innovation nowadays….. All they have to do is the late development. And that’s the clinical trials. Now that is an expensive part of the process. But it is not an innovative part of the process.” . . .innovation doesn’t only...